Solid Malignancies
📧 Sign up to get email alerts when something new happens for Solid Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating CT7001 as a single-agent therapy in adults with advanced solid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules [Phase 1]
This Phase 1 trial evaluates increasing doses and different treatment schedules of the AKT inhibitor AZD5363 (ipatasertib) in patients with …
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies. [Phase 3]
Phase 3 open-label study evaluating fixed-dose durvalumab + tremelimumab vs durvalumab alone in advanced solid malignancies; completed with …
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: IBI308 in Subjects With Advanced/Metastatic Solid Malignancies [Phase 1]
Phase 1 trial update for IBI308 in advanced/metastatic solid malignancies has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating cyclophosphamide, TAPA-pulsed dendritic cell therapy, and imiquimod in progressive or refractory sol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies [Phase 1]
Phase 1 dose-escalation study of MLN0128 in participants with advanced solid malignancies has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies [Phase 1]
Phase 1 dose-escalation study of MLN0128 (sapanisertib) in combination with paclitaxel, with/without trastuzumab, in subjects with advanced …
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase [Phase 1]
Phase 1 pharmacokinetics study of a single dose followed by multiple dose using [14C]AZD2014 in patients with solid malignancies.
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies [Phase 1]
Phase 1 trial evaluating safety and tolerability of olaparib tablets in Japanese patients with advanced solid malignancies has completed wit…
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability [Phase 1]
Phase 1 study comparing two formulations of AZD5363 and evaluating the effect of food on pharmacokinetics, safety, and tolerability in patie…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of AZD2014 in adults with advanced solid mal…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects [Phase 1]
Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of MEDI-573 in Japanese subjects with cancer or advanced…
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. [Phase 1]
Phase 1 clinical trial of ixabepilone given as a 24-hour infusion in patients with solid malignancies; study completed with results posted.